Edgestream Partners, L.P.

Position in ZTS — Zoetis Inc.

CIK 1535061 Princeton, NJ

Position in ZTS

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$4,077,048

-$5,084,936 QoQ

Shares Held

56,736

-26.8% QoQ

Ownership

0.014%

of shares outstanding

% of Portfolio

0.13%

of 13F equity value

Holder Rank

#375

of 1,412 holders

Holding Since

Jun 2023

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Edgestream Partners, L.P. holds $13,084,437 across 5 Drug Manufacturers - Specialty & Generic names. ZTS ranks #2 (31.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	UTHR	UNITED THERAPEUTICS Corp	9,178	$4,972,915
2	ZTS	Zoetis Inc. This page	56,736	$4,077,048
3	SUPN	Supernus Pharmaceuticals, Inc.	66,573	$3,096,310
4	BCRX	Biocryst Pharmaceuticals Inc	61,446	$614,460
5	PBH	Prestige Consumer Healthcare Inc.	6,848	$323,704

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,077,048	56,736	-26.8%	Shares	Sole	2026-08-11
2026-03-31	$9,161,984	77,506	+176.2%	Shares	Sole	2026-05-18
2025-12-31	$3,530,257	28,058	-72.3%	Shares	Sole	2026-02-13
2025-09-30	$14,806,267	101,191	+810.8%	Shares	Sole	2025-11-12
2025-06-30	$1,732,604	11,110	-80.0%	Shares	Sole	2025-08-13
2025-03-31	$9,157,668	55,619	+466.4%	Shares	Sole	2025-05-02
2024-12-31	$1,599,972	9,820	-7.7%	Shares	Sole	2025-02-07
2024-09-30	$2,077,866	10,635	-16.4%	Shares	Sole	2024-11-14
2023-12-31	$2,511,138	12,723	+57.1%	Shares	Sole	2024-02-14
2023-06-30	$1,394,728	8,099	—	Shares	Sole	2023-08-10
No filing history on record for this holder in this stock.